Optiray 320
peripheral arteriography, venography, aortography + 8 more
Treatment
1 Active Study for Optiray 320
Treatment for
peripheral arteriography
What is Optiray 320
Ioversol
The Generic name of this drug
Treatment Summary
Ioversol is a special type of dye used in diagnostic tests. It contains iodine and other chemicals that are soluble in water. It is used to help doctors see better during certain medical procedures.
Optiray 160
is the brand name
Optiray 320 Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Optiray 160
Ioversol
2007
5
Effectiveness
How Optiray 320 Affects Patients
Ioversol is a contrast agent used for medical imaging. After being injected, the amount of contrast present in the body will reach its highest level, but it may take up to an hour for the contrast to reach its maximum effect. For angiographies, the contrast peak is almost immediate (15-120 seconds). In those with normal kidney function, the best contrast will be seen within 5-15 minutes.
How Optiray 320 works in the body
Ioversol is a medical contrast agent used in imaging procedures. After being injected into the bloodstream, it enters the vessels and makes them visible on an X-ray or CT scan. It then diffuses out of the vessels and into the extravascular space, allowing it to be seen on the scan. In patients with a damaged blood-brain barrier, this agent can also enter the interstitial space of the affected area. Finally, Optiray is a form of ioversol that enhances computed tomography imaging by increasing the amount of iodine in the dose.
When to interrupt dosage
The suggested measure of Optiray 320 is contingent upon the diagnosed condition, such as venography, ventriculography and intravenous excretory urography. The amount of dosage is contingent on the technique of delivery as outlined in the table underneath.
Condition
Dosage
Administration
peripheral arteriography
68.0 %, , 74.0 %, 51.0 %, 64.0 %, 34.0 %, 509.0 mg/mL, 636.0 mg/mL, 741.0 mg/mL, 678.0 mg/mL, 339.0 mg/mL, 240.0 mg/mL
Solution - Intravascular, , Intravascular, Solution, Intravascular; Subarachnoid, Solution - Intravascular; Subarachnoid, Intravenous, Solution - Intravenous, Intra-arterial; Intravenous, Injection - Intra-arterial; Intravenous, Injection, Liquid - Intravascular, Liquid, Injection - Intravascular
venography
68.0 %, , 74.0 %, 51.0 %, 64.0 %, 34.0 %, 509.0 mg/mL, 636.0 mg/mL, 741.0 mg/mL, 678.0 mg/mL, 339.0 mg/mL, 240.0 mg/mL
Solution - Intravascular, , Intravascular, Solution, Intravascular; Subarachnoid, Solution - Intravascular; Subarachnoid, Intravenous, Solution - Intravenous, Intra-arterial; Intravenous, Injection - Intra-arterial; Intravenous, Injection, Liquid - Intravascular, Liquid, Injection - Intravascular
aortography
68.0 %, , 74.0 %, 51.0 %, 64.0 %, 34.0 %, 509.0 mg/mL, 636.0 mg/mL, 741.0 mg/mL, 678.0 mg/mL, 339.0 mg/mL, 240.0 mg/mL
Solution - Intravascular, , Intravascular, Solution, Intravascular; Subarachnoid, Solution - Intravascular; Subarachnoid, Intravenous, Solution - Intravenous, Intra-arterial; Intravenous, Injection - Intra-arterial; Intravenous, Injection, Liquid - Intravascular, Liquid, Injection - Intravascular
Arteriography
68.0 %, , 74.0 %, 51.0 %, 64.0 %, 34.0 %, 509.0 mg/mL, 636.0 mg/mL, 741.0 mg/mL, 678.0 mg/mL, 339.0 mg/mL, 240.0 mg/mL
Solution - Intravascular, , Intravascular, Solution, Intravascular; Subarachnoid, Solution - Intravascular; Subarachnoid, Intravenous, Solution - Intravenous, Intra-arterial; Intravenous, Injection - Intra-arterial; Intravenous, Injection, Liquid - Intravascular, Liquid, Injection - Intravascular
left ventriculography
68.0 %, , 74.0 %, 51.0 %, 64.0 %, 34.0 %, 509.0 mg/mL, 636.0 mg/mL, 741.0 mg/mL, 678.0 mg/mL, 339.0 mg/mL, 240.0 mg/mL
Solution - Intravascular, , Intravascular, Solution, Intravascular; Subarachnoid, Solution - Intravascular; Subarachnoid, Intravenous, Solution - Intravenous, Intra-arterial; Intravenous, Injection - Intra-arterial; Intravenous, Injection, Liquid - Intravascular, Liquid, Injection - Intravascular
Arteriography
68.0 %, , 74.0 %, 51.0 %, 64.0 %, 34.0 %, 509.0 mg/mL, 636.0 mg/mL, 741.0 mg/mL, 678.0 mg/mL, 339.0 mg/mL, 240.0 mg/mL
Solution - Intravascular, , Intravascular, Solution, Intravascular; Subarachnoid, Solution - Intravascular; Subarachnoid, Intravenous, Solution - Intravenous, Intra-arterial; Intravenous, Injection - Intra-arterial; Intravenous, Injection, Liquid - Intravascular, Liquid, Injection - Intravascular
computerized tomography
68.0 %, , 74.0 %, 51.0 %, 64.0 %, 34.0 %, 509.0 mg/mL, 636.0 mg/mL, 741.0 mg/mL, 678.0 mg/mL, 339.0 mg/mL, 240.0 mg/mL
Solution - Intravascular, , Intravascular, Solution, Intravascular; Subarachnoid, Solution - Intravascular; Subarachnoid, Intravenous, Solution - Intravenous, Intra-arterial; Intravenous, Injection - Intra-arterial; Intravenous, Injection, Liquid - Intravascular, Liquid, Injection - Intravascular
angiogram
68.0 %, , 74.0 %, 51.0 %, 64.0 %, 34.0 %, 509.0 mg/mL, 636.0 mg/mL, 741.0 mg/mL, 678.0 mg/mL, 339.0 mg/mL, 240.0 mg/mL
Solution - Intravascular, , Intravascular, Solution, Intravascular; Subarachnoid, Solution - Intravascular; Subarachnoid, Intravenous, Solution - Intravenous, Intra-arterial; Intravenous, Injection - Intra-arterial; Intravenous, Injection, Liquid - Intravascular, Liquid, Injection - Intravascular
coronary arteriography
68.0 %, , 74.0 %, 51.0 %, 64.0 %, 34.0 %, 509.0 mg/mL, 636.0 mg/mL, 741.0 mg/mL, 678.0 mg/mL, 339.0 mg/mL, 240.0 mg/mL
Solution - Intravascular, , Intravascular, Solution, Intravascular; Subarachnoid, Solution - Intravascular; Subarachnoid, Intravenous, Solution - Intravenous, Intra-arterial; Intravenous, Injection - Intra-arterial; Intravenous, Injection, Liquid - Intravascular, Liquid, Injection - Intravascular
intravenous excretory urography
68.0 %, , 74.0 %, 51.0 %, 64.0 %, 34.0 %, 509.0 mg/mL, 636.0 mg/mL, 741.0 mg/mL, 678.0 mg/mL, 339.0 mg/mL, 240.0 mg/mL
Solution - Intravascular, , Intravascular, Solution, Intravascular; Subarachnoid, Solution - Intravascular; Subarachnoid, Intravenous, Solution - Intravenous, Intra-arterial; Intravenous, Injection - Intra-arterial; Intravenous, Injection, Liquid - Intravascular, Liquid, Injection - Intravascular
Renal Arteriography
68.0 %, , 74.0 %, 51.0 %, 64.0 %, 34.0 %, 509.0 mg/mL, 636.0 mg/mL, 741.0 mg/mL, 678.0 mg/mL, 339.0 mg/mL, 240.0 mg/mL
Solution - Intravascular, , Intravascular, Solution, Intravascular; Subarachnoid, Solution - Intravascular; Subarachnoid, Intravenous, Solution - Intravenous, Intra-arterial; Intravenous, Injection - Intra-arterial; Intravenous, Injection, Liquid - Intravascular, Liquid, Injection - Intravascular
Warnings
Optiray 320 has one contraindication and should not be ingested when dealing with any of the conditions illustrated in the table below.
Optiray 320 Contraindications
Condition
Risk Level
Notes
Hyperthyroidism
Do Not Combine
There are 20 known major drug interactions with Optiray 320.
Common Optiray 320 Drug Interactions
Drug Name
Risk Level
Description
Acrivastine
Minor
Ioversol may decrease the excretion rate of Acrivastine which could result in a higher serum level.
Albutrepenonacog alfa
Minor
Ioversol may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.
Almasilate
Minor
Ioversol may decrease the excretion rate of Almasilate which could result in a higher serum level.
Antihemophilic factor (recombinant), PEGylated
Minor
Ioversol may decrease the excretion rate of Antihemophilic factor (recombinant), PEGylated which could result in a higher serum level.
Antithrombin III human
Minor
Ioversol may decrease the excretion rate of Antithrombin III human which could result in a higher serum level.
Optiray 320 Toxicity & Overdose Risk
Taking too much Ioversol can cause dangerous side effects, especially to the lungs and heart. Treatment should focus on supporting vital functions and providing symptom relief. The drug is not believed to be carcinogenic or affect fertility, but animals given high doses showed signs of toxicity. People with kidney or liver problems, thyroid issues, or anuria should be especially careful when taking Ioversol. In some cases, serious reactions such as death, seizures, coma, paralysis, kidney failure, and brain swelling have occurred when Ioversol was mistakenly injected into the spine.
Optiray 320 Novel Uses: Which Conditions Have a Clinical Trial Featuring Optiray 320?
An active trial is underway to determine the efficacy of Optiray 320 in Venography, Arteriography and Computerized Tomography.
Condition
Clinical Trials
Trial Phases
intravenous excretory urography
0 Actively Recruiting
aortography
0 Actively Recruiting
Arteriography
0 Actively Recruiting
Arteriography
0 Actively Recruiting
Renal Arteriography
0 Actively Recruiting
venography
0 Actively Recruiting
peripheral arteriography
0 Actively Recruiting
coronary arteriography
0 Actively Recruiting
computerized tomography
1 Actively Recruiting
Phase 2
angiogram
0 Actively Recruiting
left ventriculography
0 Actively Recruiting
Patient Q&A Section about optiray 320
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What optiray 320?
"What is Optiray 320?
Optiray 320 is a substance that allows blood vessels and other tissues to be seen more clearly on a CT scan or other X-ray examination. It contains iodine, which absorbs X-rays."
Answered by AI
What is optiray used for?
"Optiray Injection is a prescription medicine used to help diagnose problems with the body, brain, heart, or urinary system. It can be used alone or with other medications."
Answered by AI
Can you drink optiray 300?
"Optiray 300 is an injection given into a vein or artery by a healthcare provider. You should drink extra fluids before and after your radiologic test, as Optiray 300 can cause you to become dehydrated, which can have dangerous effects on your kidneys."
Answered by AI
Who makes optiray contrast?
"Optiray® is a contrast agent used in X-ray and MRI exams. It is manufactured by Guerbet LLC, and is available only with a prescription."
Answered by AI